nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—STK10—renal vein—membranous glomerulonephritis	0.0753	0.166	CbGeAlD
Crizotinib—INSRR—kidney—membranous glomerulonephritis	0.0215	0.0475	CbGeAlD
Crizotinib—PRKD1—nephron tubule—membranous glomerulonephritis	0.00989	0.0218	CbGeAlD
Crizotinib—NEK9—kidney—membranous glomerulonephritis	0.00953	0.021	CbGeAlD
Crizotinib—PRKD1—kidney—membranous glomerulonephritis	0.00869	0.0192	CbGeAlD
Crizotinib—PRKD3—kidney—membranous glomerulonephritis	0.00835	0.0184	CbGeAlD
Crizotinib—MET—epithelium—membranous glomerulonephritis	0.00806	0.0178	CbGeAlD
Crizotinib—DSTYK—cortex of kidney—membranous glomerulonephritis	0.00794	0.0175	CbGeAlD
Crizotinib—MET—kidney—membranous glomerulonephritis	0.00722	0.0159	CbGeAlD
Crizotinib—ACVR1B—kidney—membranous glomerulonephritis	0.00668	0.0147	CbGeAlD
Crizotinib—BMPR1B—epithelium—membranous glomerulonephritis	0.00646	0.0143	CbGeAlD
Crizotinib—IGF1R—epithelium—membranous glomerulonephritis	0.00633	0.014	CbGeAlD
Crizotinib—TIE1—epithelium—membranous glomerulonephritis	0.00616	0.0136	CbGeAlD
Crizotinib—TESK1—nephron tubule—membranous glomerulonephritis	0.00607	0.0134	CbGeAlD
Crizotinib—NUAK2—nephron tubule—membranous glomerulonephritis	0.00576	0.0127	CbGeAlD
Crizotinib—FER—cortex of kidney—membranous glomerulonephritis	0.00576	0.0127	CbGeAlD
Crizotinib—ACVR1—nephron tubule—membranous glomerulonephritis	0.00572	0.0126	CbGeAlD
Crizotinib—IGF1R—kidney—membranous glomerulonephritis	0.00568	0.0125	CbGeAlD
Crizotinib—AURKA—kidney—membranous glomerulonephritis	0.00538	0.0119	CbGeAlD
Crizotinib—STK3—cortex of kidney—membranous glomerulonephritis	0.00538	0.0119	CbGeAlD
Crizotinib—TESK1—cortex of kidney—membranous glomerulonephritis	0.0052	0.0115	CbGeAlD
Crizotinib—RIPK2—nephron tubule—membranous glomerulonephritis	0.00517	0.0114	CbGeAlD
Crizotinib—RIPK2—epithelium—membranous glomerulonephritis	0.00506	0.0112	CbGeAlD
Crizotinib—ACVR1—kidney—membranous glomerulonephritis	0.00503	0.0111	CbGeAlD
Crizotinib—LIMK2—cortex of kidney—membranous glomerulonephritis	0.00495	0.0109	CbGeAlD
Crizotinib—NUAK2—cortex of kidney—membranous glomerulonephritis	0.00493	0.0109	CbGeAlD
Crizotinib—MAP3K2—nephron tubule—membranous glomerulonephritis	0.0049	0.0108	CbGeAlD
Crizotinib—ACVR1—cortex of kidney—membranous glomerulonephritis	0.00489	0.0108	CbGeAlD
Crizotinib—PTK2—nephron tubule—membranous glomerulonephritis	0.0048	0.0106	CbGeAlD
Crizotinib—TBK1—nephron tubule—membranous glomerulonephritis	0.0048	0.0106	CbGeAlD
Crizotinib—TYK2—nephron tubule—membranous glomerulonephritis	0.00476	0.0105	CbGeAlD
Crizotinib—IRAK1—nephron tubule—membranous glomerulonephritis	0.0047	0.0104	CbGeAlD
Crizotinib—PTK2—epithelium—membranous glomerulonephritis	0.0047	0.0104	CbGeAlD
Crizotinib—PTK2B—kidney—membranous glomerulonephritis	0.00458	0.0101	CbGeAlD
Crizotinib—RPS6KB1—epithelium—membranous glomerulonephritis	0.00452	0.00998	CbGeAlD
Crizotinib—SLK—nephron tubule—membranous glomerulonephritis	0.0044	0.0097	CbGeAlD
Crizotinib—EPHB4—nephron tubule—membranous glomerulonephritis	0.00436	0.00964	CbGeAlD
Crizotinib—EPHA2—nephron tubule—membranous glomerulonephritis	0.00428	0.00945	CbGeAlD
Crizotinib—EPHB4—epithelium—membranous glomerulonephritis	0.00428	0.00944	CbGeAlD
Crizotinib—JAK2—epithelium—membranous glomerulonephritis	0.00425	0.00938	CbGeAlD
Crizotinib—PTK2—kidney—membranous glomerulonephritis	0.00421	0.0093	CbGeAlD
Crizotinib—TBK1—kidney—membranous glomerulonephritis	0.00421	0.0093	CbGeAlD
Crizotinib—EPHA2—epithelium—membranous glomerulonephritis	0.0042	0.00926	CbGeAlD
Crizotinib—TYK2—kidney—membranous glomerulonephritis	0.00419	0.00924	CbGeAlD
Crizotinib—MAP3K3—nephron tubule—membranous glomerulonephritis	0.00418	0.00922	CbGeAlD
Crizotinib—PTK2—cortex of kidney—membranous glomerulonephritis	0.0041	0.00906	CbGeAlD
Crizotinib—TBK1—cortex of kidney—membranous glomerulonephritis	0.0041	0.00906	CbGeAlD
Crizotinib—TEK—epithelium—membranous glomerulonephritis	0.00409	0.00904	CbGeAlD
Crizotinib—TYK2—cortex of kidney—membranous glomerulonephritis	0.00408	0.009	CbGeAlD
Crizotinib—RPS6KB1—kidney—membranous glomerulonephritis	0.00405	0.00895	CbGeAlD
Crizotinib—IRAK1—cortex of kidney—membranous glomerulonephritis	0.00402	0.00888	CbGeAlD
Crizotinib—RPS6KB1—cortex of kidney—membranous glomerulonephritis	0.00395	0.00872	CbGeAlD
Crizotinib—AXL—cortex of kidney—membranous glomerulonephritis	0.00391	0.00863	CbGeAlD
Crizotinib—YES1—nephron tubule—membranous glomerulonephritis	0.00386	0.00852	CbGeAlD
Crizotinib—EPHB4—kidney—membranous glomerulonephritis	0.00384	0.00847	CbGeAlD
Crizotinib—JAK2—kidney—membranous glomerulonephritis	0.00381	0.00841	CbGeAlD
Crizotinib—TAOK3—nephron tubule—membranous glomerulonephritis	0.00381	0.00841	CbGeAlD
Crizotinib—SLK—cortex of kidney—membranous glomerulonephritis	0.00376	0.00831	CbGeAlD
Crizotinib—EPHB4—cortex of kidney—membranous glomerulonephritis	0.00374	0.00825	CbGeAlD
Crizotinib—JAK2—cortex of kidney—membranous glomerulonephritis	0.00371	0.00819	CbGeAlD
Crizotinib—TEK—kidney—membranous glomerulonephritis	0.00367	0.0081	CbGeAlD
Crizotinib—SRC—epithelium—membranous glomerulonephritis	0.00364	0.00803	CbGeAlD
Crizotinib—MAP3K3—cortex of kidney—membranous glomerulonephritis	0.00357	0.00789	CbGeAlD
Crizotinib—TEK—cortex of kidney—membranous glomerulonephritis	0.00357	0.00789	CbGeAlD
Crizotinib—MAP4K5—cortex of kidney—membranous glomerulonephritis	0.00357	0.00789	CbGeAlD
Crizotinib—EPHB6—cortex of kidney—membranous glomerulonephritis	0.00342	0.00754	CbGeAlD
Crizotinib—YES1—kidney—membranous glomerulonephritis	0.00339	0.00748	CbGeAlD
Crizotinib—STK10—kidney—membranous glomerulonephritis	0.00336	0.00742	CbGeAlD
Crizotinib—TAOK3—kidney—membranous glomerulonephritis	0.00335	0.00739	CbGeAlD
Crizotinib—YES1—cortex of kidney—membranous glomerulonephritis	0.0033	0.00729	CbGeAlD
Crizotinib—SRC—kidney—membranous glomerulonephritis	0.00326	0.0072	CbGeAlD
Crizotinib—TAOK3—cortex of kidney—membranous glomerulonephritis	0.00326	0.0072	CbGeAlD
Crizotinib—ABL1—nephron tubule—membranous glomerulonephritis	0.00263	0.00581	CbGeAlD
Crizotinib—ABL1—kidney—membranous glomerulonephritis	0.00231	0.00511	CbGeAlD
Crizotinib—ABL1—cortex of kidney—membranous glomerulonephritis	0.00225	0.00498	CbGeAlD
Crizotinib—CYP3A5—nephron tubule—membranous glomerulonephritis	0.00154	0.0034	CbGeAlD
Crizotinib—CYP3A5—kidney—membranous glomerulonephritis	0.00135	0.00299	CbGeAlD
Crizotinib—CYP3A5—cortex of kidney—membranous glomerulonephritis	0.00132	0.00291	CbGeAlD
Crizotinib—CYP3A4—kidney—membranous glomerulonephritis	0.00102	0.00224	CbGeAlD
Crizotinib—ABCB1—nephron tubule—membranous glomerulonephritis	0.000819	0.00181	CbGeAlD
Crizotinib—ABCB1—epithelium—membranous glomerulonephritis	0.000803	0.00177	CbGeAlD
Crizotinib—ABCB1—kidney—membranous glomerulonephritis	0.00072	0.00159	CbGeAlD
Crizotinib—ABCB1—cortex of kidney—membranous glomerulonephritis	0.000701	0.00155	CbGeAlD
Crizotinib—IRAK1—Immune System—HLA-DQA1—membranous glomerulonephritis	8.31e-05	0.000152	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—APOE—membranous glomerulonephritis	8.25e-05	0.000151	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—C3—membranous glomerulonephritis	8.19e-05	0.00015	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—APOA1—membranous glomerulonephritis	8.16e-05	0.000149	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—APOE—membranous glomerulonephritis	8.08e-05	0.000148	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DQA1—membranous glomerulonephritis	8.06e-05	0.000147	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HLA-DRB1—membranous glomerulonephritis	8.05e-05	0.000147	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—APOA1—membranous glomerulonephritis	7.98e-05	0.000146	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—IL1B—membranous glomerulonephritis	7.96e-05	0.000146	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—IL1B—membranous glomerulonephritis	7.96e-05	0.000146	CbGpPWpGaD
Crizotinib—CDK7—Disease—APOE—membranous glomerulonephritis	7.96e-05	0.000146	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-DRB1—membranous glomerulonephritis	7.93e-05	0.000145	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—RHOA—membranous glomerulonephritis	7.9e-05	0.000144	CbGpPWpGaD
Crizotinib—CDK7—Disease—APOA1—membranous glomerulonephritis	7.87e-05	0.000144	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—RHOA—membranous glomerulonephritis	7.85e-05	0.000143	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD40LG—membranous glomerulonephritis	7.84e-05	0.000143	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DQA1—membranous glomerulonephritis	7.81e-05	0.000143	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD40LG—membranous glomerulonephritis	7.8e-05	0.000142	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—MMP9—membranous glomerulonephritis	7.77e-05	0.000142	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-DRB1—membranous glomerulonephritis	7.74e-05	0.000142	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD40LG—membranous glomerulonephritis	7.74e-05	0.000141	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—MMP9—membranous glomerulonephritis	7.74e-05	0.000141	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-DRB1—membranous glomerulonephritis	7.72e-05	0.000141	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	7.66e-05	0.00014	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—RHOA—membranous glomerulonephritis	7.65e-05	0.00014	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—IL1B—membranous glomerulonephritis	7.59e-05	0.000139	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—MMP9—membranous glomerulonephritis	7.54e-05	0.000138	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD40—membranous glomerulonephritis	7.53e-05	0.000138	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PLG—membranous glomerulonephritis	7.52e-05	0.000137	CbGpPWpGaD
Crizotinib—SRC—Disease—LRP2—membranous glomerulonephritis	7.5e-05	0.000137	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD40—membranous glomerulonephritis	7.49e-05	0.000137	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—MMP9—membranous glomerulonephritis	7.44e-05	0.000136	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PLG—membranous glomerulonephritis	7.41e-05	0.000135	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD40LG—membranous glomerulonephritis	7.34e-05	0.000134	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—APOA1—membranous glomerulonephritis	7.33e-05	0.000134	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—MMP9—membranous glomerulonephritis	7.27e-05	0.000133	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—LRP2—membranous glomerulonephritis	7.24e-05	0.000132	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—MMP9—membranous glomerulonephritis	7.24e-05	0.000132	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—MMP9—membranous glomerulonephritis	7.24e-05	0.000132	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—C3—membranous glomerulonephritis	7.17e-05	0.000131	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD40LG—membranous glomerulonephritis	7.12e-05	0.00013	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—RHOA—membranous glomerulonephritis	7.1e-05	0.00013	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PLG—membranous glomerulonephritis	7.09e-05	0.00013	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—ALB—membranous glomerulonephritis	7.09e-05	0.00013	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD79A—membranous glomerulonephritis	7.08e-05	0.000129	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—ALB—membranous glomerulonephritis	7.06e-05	0.000129	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD40—membranous glomerulonephritis	7.04e-05	0.000129	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD79A—membranous glomerulonephritis	7.04e-05	0.000129	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—RHOA—membranous glomerulonephritis	6.98e-05	0.000128	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—RHOA—membranous glomerulonephritis	6.95e-05	0.000127	CbGpPWpGaD
Crizotinib—PTK2—Immune System—C3—membranous glomerulonephritis	6.93e-05	0.000127	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—RHOA—membranous glomerulonephritis	6.91e-05	0.000126	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD40LG—membranous glomerulonephritis	6.9e-05	0.000126	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—C3—membranous glomerulonephritis	6.89e-05	0.000126	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—C3—membranous glomerulonephritis	6.89e-05	0.000126	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PLG—membranous glomerulonephritis	6.87e-05	0.000126	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—MMP9—membranous glomerulonephritis	6.86e-05	0.000125	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—RHOA—membranous glomerulonephritis	6.85e-05	0.000125	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—MMP9—membranous glomerulonephritis	6.85e-05	0.000125	CbGpPWpGaD
Crizotinib—YES1—Immune System—C3—membranous glomerulonephritis	6.84e-05	0.000125	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—RHOA—membranous glomerulonephritis	6.82e-05	0.000125	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LRP2—membranous glomerulonephritis	6.78e-05	0.000124	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—ALB—membranous glomerulonephritis	6.63e-05	0.000121	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD79A—membranous glomerulonephritis	6.62e-05	0.000121	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—RHOA—membranous glomerulonephritis	6.54e-05	0.000119	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DQA1—membranous glomerulonephritis	6.53e-05	0.000119	CbGpPWpGaD
Crizotinib—TBK1—Immune System—IL1B—membranous glomerulonephritis	6.5e-05	0.000119	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DQA1—membranous glomerulonephritis	6.5e-05	0.000119	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—APOA1—membranous glomerulonephritis	6.49e-05	0.000119	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—C3—membranous glomerulonephritis	6.48e-05	0.000119	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—RHOA—membranous glomerulonephritis	6.41e-05	0.000117	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—C3—membranous glomerulonephritis	6.41e-05	0.000117	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—C3—membranous glomerulonephritis	6.35e-05	0.000116	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DRB1—membranous glomerulonephritis	6.32e-05	0.000115	CbGpPWpGaD
Crizotinib—TYK2—Immune System—C3—membranous glomerulonephritis	6.3e-05	0.000115	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	6.28e-05	0.000115	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—MMP9—membranous glomerulonephritis	6.27e-05	0.000115	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—RHOA—membranous glomerulonephritis	6.25e-05	0.000114	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—IL1B—membranous glomerulonephritis	6.24e-05	0.000114	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DRB1—membranous glomerulonephritis	6.23e-05	0.000114	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD40—membranous glomerulonephritis	6.17e-05	0.000113	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—RHOA—membranous glomerulonephritis	6.11e-05	0.000112	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DQA1—membranous glomerulonephritis	6.11e-05	0.000112	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—C3—membranous glomerulonephritis	6.1e-05	0.000111	CbGpPWpGaD
Crizotinib—CDK7—Disease—RHOA—membranous glomerulonephritis	6.03e-05	0.00011	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—APOE—membranous glomerulonephritis	5.97e-05	0.000109	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LRP2—membranous glomerulonephritis	5.93e-05	0.000108	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DRB1—membranous glomerulonephritis	5.91e-05	0.000108	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—APOA1—membranous glomerulonephritis	5.9e-05	0.000108	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PLG—membranous glomerulonephritis	5.9e-05	0.000108	CbGpPWpGaD
Crizotinib—JAK3—Immune System—IL1B—membranous glomerulonephritis	5.88e-05	0.000108	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PLG—membranous glomerulonephritis	5.82e-05	0.000106	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—ALB—membranous glomerulonephritis	5.81e-05	0.000106	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD79A—membranous glomerulonephritis	5.8e-05	0.000106	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD40LG—membranous glomerulonephritis	5.77e-05	0.000105	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—C3—membranous glomerulonephritis	5.75e-05	0.000105	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD40LG—membranous glomerulonephritis	5.74e-05	0.000105	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DRB1—membranous glomerulonephritis	5.74e-05	0.000105	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—C3—membranous glomerulonephritis	5.71e-05	0.000104	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—MMP9—membranous glomerulonephritis	5.64e-05	0.000103	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—C3—membranous glomerulonephritis	5.63e-05	0.000103	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—RHOA—membranous glomerulonephritis	5.62e-05	0.000103	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	5.56e-05	0.000102	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—MMP9—membranous glomerulonephritis	5.55e-05	0.000101	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—TBXAS1—membranous glomerulonephritis	5.53e-05	0.000101	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—MMP9—membranous glomerulonephritis	5.52e-05	0.000101	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PLG—membranous glomerulonephritis	5.52e-05	0.000101	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—MMP9—membranous glomerulonephritis	5.48e-05	0.0001	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD40—membranous glomerulonephritis	5.46e-05	9.98e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—APOE—membranous glomerulonephritis	5.41e-05	9.89e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD40LG—membranous glomerulonephritis	5.4e-05	9.87e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—C3—membranous glomerulonephritis	5.39e-05	9.85e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PLG—membranous glomerulonephritis	5.36e-05	9.79e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DQA1—membranous glomerulonephritis	5.35e-05	9.78e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—APOA1—membranous glomerulonephritis	5.35e-05	9.78e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—APOE—membranous glomerulonephritis	5.32e-05	9.72e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—APOA1—membranous glomerulonephritis	5.26e-05	9.61e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LRP2—membranous glomerulonephritis	5.25e-05	9.6e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL1B—membranous glomerulonephritis	5.24e-05	9.58e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—APOE—membranous glomerulonephritis	5.24e-05	9.58e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—C3—membranous glomerulonephritis	5.22e-05	9.55e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—C3—membranous glomerulonephritis	5.22e-05	9.55e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—MMP9—membranous glomerulonephritis	5.19e-05	9.49e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—APOA1—membranous glomerulonephritis	5.18e-05	9.47e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL1B—membranous glomerulonephritis	5.17e-05	9.45e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—ALB—membranous glomerulonephritis	5.14e-05	9.4e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD79A—membranous glomerulonephritis	5.13e-05	9.39e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—C3—membranous glomerulonephritis	5.1e-05	9.32e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—C3—membranous glomerulonephritis	5.07e-05	9.28e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—RHOA—membranous glomerulonephritis	5.07e-05	9.26e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL1B—membranous glomerulonephritis	5.04e-05	9.22e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL1B—membranous glomerulonephritis	5.03e-05	9.19e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—APOE—membranous glomerulonephritis	5.02e-05	9.17e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—RHOA—membranous glomerulonephritis	4.97e-05	9.09e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—MMP9—membranous glomerulonephritis	4.96e-05	9.07e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—APOA1—membranous glomerulonephritis	4.96e-05	9.06e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—LRP2—membranous glomerulonephritis	4.93e-05	9e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—APOE—membranous glomerulonephritis	4.86e-05	8.89e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—RHOA—membranous glomerulonephritis	4.86e-05	8.88e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—MMP9—membranous glomerulonephritis	4.85e-05	8.87e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—APOA1—membranous glomerulonephritis	4.81e-05	8.79e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—C3—membranous glomerulonephritis	4.77e-05	8.72e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	4.75e-05	8.69e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PLA2G1B—membranous glomerulonephritis	4.74e-05	8.67e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DQA1—membranous glomerulonephritis	4.74e-05	8.66e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD40LG—membranous glomerulonephritis	4.73e-05	8.64e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DRB1—membranous glomerulonephritis	4.64e-05	8.49e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DRB1—membranous glomerulonephritis	4.62e-05	8.45e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—RHOA—membranous glomerulonephritis	4.52e-05	8.26e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—C3—membranous glomerulonephritis	4.48e-05	8.19e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—C3—membranous glomerulonephritis	4.42e-05	8.08e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DRB1—membranous glomerulonephritis	4.35e-05	7.95e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PLG—membranous glomerulonephritis	4.34e-05	7.93e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—C3—membranous glomerulonephritis	4.19e-05	7.66e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD40LG—membranous glomerulonephritis	4.19e-05	7.65e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—C3—membranous glomerulonephritis	4.18e-05	7.64e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—APOE—membranous glomerulonephritis	4.17e-05	7.63e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	4.17e-05	7.62e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—APOA1—membranous glomerulonephritis	4.13e-05	7.54e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—APOE—membranous glomerulonephritis	4.12e-05	7.52e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL1B—membranous glomerulonephritis	4.11e-05	7.52e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—APOE—membranous glomerulonephritis	4.1e-05	7.5e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—RHOA—membranous glomerulonephritis	4.1e-05	7.49e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—C3—membranous glomerulonephritis	4.07e-05	7.44e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—APOA1—membranous glomerulonephritis	4.07e-05	7.44e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PLG—membranous glomerulonephritis	4.06e-05	7.42e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL1B—membranous glomerulonephritis	4.06e-05	7.42e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—APOA1—membranous glomerulonephritis	4.05e-05	7.41e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—RHOA—membranous glomerulonephritis	4.05e-05	7.41e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—RHOA—membranous glomerulonephritis	4.03e-05	7.36e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP9—membranous glomerulonephritis	4.02e-05	7.36e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—RHOA—membranous glomerulonephritis	3.97e-05	7.25e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—APOE—membranous glomerulonephritis	3.9e-05	7.13e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—APOA1—membranous glomerulonephritis	3.86e-05	7.05e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL1B—membranous glomerulonephritis	3.85e-05	7.04e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DRB1—membranous glomerulonephritis	3.81e-05	6.96e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—RHOA—membranous glomerulonephritis	3.8e-05	6.94e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—APOE—membranous glomerulonephritis	3.79e-05	6.93e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—APOA1—membranous glomerulonephritis	3.75e-05	6.85e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL1B—membranous glomerulonephritis	3.74e-05	6.83e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	3.72e-05	6.79e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—C3—membranous glomerulonephritis	3.7e-05	6.76e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—RHOA—membranous glomerulonephritis	3.68e-05	6.73e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—RHOA—membranous glomerulonephritis	3.68e-05	6.73e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—APOE—membranous glomerulonephritis	3.59e-05	6.57e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MMP9—membranous glomerulonephritis	3.59e-05	6.56e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	3.58e-05	6.54e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PLG—membranous glomerulonephritis	3.55e-05	6.5e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—APOA1—membranous glomerulonephritis	3.55e-05	6.49e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DRB1—membranous glomerulonephritis	3.37e-05	6.16e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	3.33e-05	6.08e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—C3—membranous glomerulonephritis	3.3e-05	6.03e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP9—membranous glomerulonephritis	3.2e-05	5.84e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—APOE—membranous glomerulonephritis	3.18e-05	5.81e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCA1—membranous glomerulonephritis	3.17e-05	5.8e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RHOA—membranous glomerulonephritis	3.16e-05	5.77e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP9—membranous glomerulonephritis	3.15e-05	5.76e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PLG—membranous glomerulonephritis	3.15e-05	5.75e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—APOA1—membranous glomerulonephritis	3.14e-05	5.75e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RHOA—membranous glomerulonephritis	3.12e-05	5.69e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—RHOA—membranous glomerulonephritis	3.1e-05	5.67e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—C3—membranous glomerulonephritis	3.08e-05	5.64e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APOE—membranous glomerulonephritis	3.07e-05	5.61e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APOA1—membranous glomerulonephritis	3.03e-05	5.54e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—membranous glomerulonephritis	3.03e-05	5.53e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP9—membranous glomerulonephritis	3.01e-05	5.51e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—membranous glomerulonephritis	3.01e-05	5.51e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RHOA—membranous glomerulonephritis	2.95e-05	5.4e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP9—membranous glomerulonephritis	2.92e-05	5.34e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOE—membranous glomerulonephritis	2.87e-05	5.25e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RHOA—membranous glomerulonephritis	2.87e-05	5.24e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOA1—membranous glomerulonephritis	2.84e-05	5.19e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—membranous glomerulonephritis	2.83e-05	5.18e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—RHOA—membranous glomerulonephritis	2.72e-05	4.97e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—C3—membranous glomerulonephritis	2.7e-05	4.94e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	2.63e-05	4.82e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	2.57e-05	4.7e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOE—membranous glomerulonephritis	2.52e-05	4.6e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—membranous glomerulonephritis	2.51e-05	4.58e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOA1—membranous glomerulonephritis	2.49e-05	4.55e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—membranous glomerulonephritis	2.48e-05	4.53e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—membranous glomerulonephritis	2.47e-05	4.52e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—RHOA—membranous glomerulonephritis	2.41e-05	4.4e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	2.4e-05	4.38e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—C3—membranous glomerulonephritis	2.39e-05	4.37e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—membranous glomerulonephritis	2.35e-05	4.29e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RHOA—membranous glomerulonephritis	2.32e-05	4.25e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	2.29e-05	4.19e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—membranous glomerulonephritis	2.28e-05	4.16e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOE—membranous glomerulonephritis	2.23e-05	4.07e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	2.2e-05	4.03e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOA1—membranous glomerulonephritis	2.2e-05	4.02e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—membranous glomerulonephritis	2.2e-05	4.01e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RHOA—membranous glomerulonephritis	2.17e-05	3.97e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOE—membranous glomerulonephritis	2.09e-05	3.82e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOA1—membranous glomerulonephritis	2.06e-05	3.77e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RHOA—membranous glomerulonephritis	1.9e-05	3.48e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—membranous glomerulonephritis	1.84e-05	3.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—membranous glomerulonephritis	1.73e-05	3.16e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RHOA—membranous glomerulonephritis	1.69e-05	3.08e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—membranous glomerulonephritis	1.64e-05	2.99e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOE—membranous glomerulonephritis	1.58e-05	2.88e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	1.56e-05	2.85e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—membranous glomerulonephritis	1.51e-05	2.76e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	1.48e-05	2.7e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—membranous glomerulonephritis	1.34e-05	2.45e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—membranous glomerulonephritis	1.23e-05	2.26e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	9.71e-06	1.77e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	9.6e-06	1.75e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	7.6e-06	1.39e-05	CbGpPWpGaD
